- $168.48m
- $110.94m
- $212.45m
Annual balance sheet for LifeMD, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 9.18 | 41.3 | 3.96 | 33.1 | 35 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.998 | 0.98 | 2.83 | 5.28 | 8.22 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 12.4 | 44.9 | 11.3 | 42.6 | 48.7 |
| Net Property, Plant And Equipment | 0.274 | 1.99 | 1.68 | 1.07 | 7.88 |
| Net Intangible Assets | |||||
| Total Assets | 13.4 | 49.9 | 25.7 | 58.5 | 72.5 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 13.9 | 22.8 | 31.4 | 34.8 | 60.3 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 12 | 23.1 | 32.5 | 55 | 77.9 |
| Redeemable Preferred Stock | |||||
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Total Equity | 1.35 | 26.9 | -6.83 | 3.51 | -5.49 |
| Total Liabilities & Shareholders' Equity | 13.4 | 49.9 | 25.7 | 58.5 | 72.5 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |